Heart Failure and Sleep Apnea: Exercise Training and Continuous Positive Airway Pressure
CPAP
Comparison Between Exercise Training and CPAP Treatment for Patients With Heart Failure and Sleep Apnea.
1 other identifier
interventional
80
1 country
1
Brief Summary
Introduction. Heart failure is the result of primary ventricular dysfunction followed by neurohormorais changes, distribution of cardiac output, peripheral circulation, the skeletal and respiratory muscles, which determine their clinical and prognosis. Despite the advancement in treatment, morbidity and mortality remain high. Physical training appears as a therapeutic strategy, because most of its beneficial effects is by inducing changes in peripheral physiological changes resulting from heart failure. Associated factors that may contribute to its progression and worse prognosis, now beginning to be studied, such as sleep apnea, the diagnosis provides important prognostic information and a potential therapeutic option for these patients. Objectives. Demonstrate the benefits of physical training for patients with heart failure and sleep apnea, and compare treatment with CPAP alone and associated with the exercise program. Will also be assessed risk and adherence to physical training. Material and Methods. The design will be prospective, longitudinal, randomized consecutive patients. After screening and baseline evaluations the patients will be randomized into Group 1 (CPAP, n = 20), Group 2 (CPAP + Physical training, n = 20), Group 3 (Physical Training, n = 20) and Group 4 (Control without intervention, n = 20). Outcomes (baseline and 3 months): Quality of sleep (polysomnography), Quality of life (Minnesota and SF-36), sexual function (QS-M and QS-F) and functional capacity (cardiopulmonary exercise testing and isokinetic testing). Physical training: aerobic and resistance exercises three times a week for three months. CPAP therapy:after polysomnography for titration with ventilator servo-assisted, and outpatient follow monthly, for three months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Mar 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2012
CompletedFirst Posted
Study publicly available on registry
February 23, 2012
CompletedStudy Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedAugust 9, 2013
August 1, 2013
1.4 years
February 15, 2012
August 6, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Polysomnography
To evaluate changes from Baseline in quality of sleep, mainly sleep apnea, after 3 months. Overnight polysomnography will be perform using a digital system with 17 channels(EMBLA, Medicare Medical Devices). The following variables will be monitor: electroencephalogram, electrooculogram, electromyogram, electrocardiogram,snoring and body position. Airflow will be monitor using a thermocouple and pressure transducer. Chest and abdominal piezo-sensors will monitor respiratory effort. Arterial oxygen saturation and pulse will be record with a pulse oxymeter.
Two evaluations (baseline and 3 month)
Secondary Outcomes (4)
Cardiopulmonary exercise testing
Two evaluations (baseline and 3 month)
Isokinetic strength and endurance
Two evaluations (baseline and 3 month)
Quality of Life
Two evaluations (baseline and 3 month)
Sexual Function
Two evaluations (baseline and 3 month)
Study Arms (4)
Control group
NO INTERVENTIONExercise group
EXPERIMENTALCPAP group
EXPERIMENTALExercise and CPAP group
EXPERIMENTALInterventions
It consisted of three sessions/week, on non-consecutive days. The aerobic protocol consisted of a warm-up (strengthening exercises, 10 minutes), aerobic exercise (30 minutes in the first month and 45 minutes in the last two months) and cool-down (strengthening exercises, 10 minutes). The aerobic exercise intensity was established by heart rate levels that corresponded to anaerobic threshold, 10 heart rates down and 10 heart rates up, assessed by cardiopulmonary exercise testing. The strength training consisted of eight exercises attending the major muscle groups and the intensity was determined by 50-60% of one-repetition maximum (1-RM) and the progression of the training will be monthly: first month (a series of 12 repetitions with 50% 1-RM), second month (1 set of 15 repetitions with 60% 1-RM) and third months (2 sets of 10 repetitions with 60% 1-RM).
The CPAP treatment will be according to protocol of the Department of Psychobiology. Titration will be perform after randomization with ventilation device servo-assisted so as to ensure positive pressure within the first 24 hours of treatment. The treatment will be for three months.
The patients randomized for this group will perform both Exercise protocol and CPAP treatment at the same time for three months.
Eligibility Criteria
You may qualify if:
- Age range 20-70 years
- New York Heart Association Class II-III
- Clinically stable for one month
- Ejection fraction \<40%
- Peak VO2 \<20 ml/kg/min
- Stable and optimized medical therapy at least one month before the study
- B-blocker therapy
- Clinical and polysomnographic diagnosis of sleep apnea (IAH\>10)
You may not qualify if:
- Patients with previous treatment of sleep apnea
- New York Heart Association Class IV
- Clinical instability
- Poor adherence to drug treatment
- Myocardial infarction or revascularization within the past two months
- Unstable angina
- Symptomatic arrhythmias (pacemaker and defibrillator)
- Obstructive aortic or mitral valvular disease
- Hypertrophic cardiomyopathy
- Abnormal exercise testing
- Pulmonary arterial pressure \>50mmHg
- Chronic obstructive pulmonary disease
- Intermittent leg claudication
- Musculoskeletal disorders or psychiatric disease that prevents the patient from understanding and following the exercise prescription safely
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Federal de Sao Paulo
São Paulo, São Paulo, 04023-062, Brazil
Related Publications (1)
Bittencourt L, Javaheri S, Servantes DM, Kravchychyn ACP, Almeida DR, Tufik S. In patients with heart failure, enhanced ventilatory response to exercise is associated with severe obstructive sleep apnea. J Clin Sleep Med. 2021 Sep 1;17(9):1875-1880. doi: 10.5664/jcsm.9396.
PMID: 33949944DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Denise M Servantes, PT
Federal University of São Paulo
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 15, 2012
First Posted
February 23, 2012
Study Start
March 1, 2012
Primary Completion
August 1, 2013
Study Completion
October 1, 2013
Last Updated
August 9, 2013
Record last verified: 2013-08